FEB 13, 2016 08:19 AM PST
Bacteria's Killer Trait Becomes New Drug Delivery System
WRITTEN BY: Xuan Pham
4 12 2235
R bodies in different states

Imagine a nanoscale needle that can pierce cells precisely and on command. Scientists from Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) have developed just this, possibly revolutionizing the future of drug delivery.
 
Published in the American Chemical Society Synthetic Biology, the discovery adapts bacterial protein polymers known as “R bodies” into precise, retractable nanoneedles. Controlled by pH levels, the nanoneedles extend to puncture cell membranes to release encapsulated cargo. Once pH levels change, they quickly reverse to the coiled form, ready for action yet again.
 
"This is one of nature’s innovations, but the discovery here is our ability to translate this from nature into a system that we can now engineer and control," said Pamela Silver, senior author on the study and Wyss Core Faculty member.
 
In nature, R bodies are produced by the Paramecium endosymbionts as a form of deadly self-defense. R bodies exist as coiled proteinaceous ribbons at low pH. In response to being ingested by another bacterial strain, the “killer strain” uses the differences in pH levels to activate its killer trait – extension of the R bodies – to rupture the host cell’s membrane. Toxins are then released which kills the host paramecium.
 
Impressed by these biological javelins, the research team at Harvard adapted this defense mechanism into a new way to deliver drugs to targeted cells. They expressed and purified the R bodies from E. coli. They then fine-tuned the extension process by screening for mutants that have altered pH sensitivity. Ultimately, they derived at a system of synthetic pistons that respond to pH levels to puncture E. coli membranes, releasing encapsulated cargo.
 
"Our research establishes R bodies as biological machines that we can use to break through membranes,” said Jessica Polka, first author of the study. “These actuators don’t consume molecular fuel and are extremely robust; we believe they could one day be used to deliver material to mammalian cells."
 
The system has many advantages, including its tunable platform, which allows for controlled release of trapped content. The authors see this as a potential way to deliver toxins or other pharmaceutical payloads directly to targeted cells. For cancer, this system could more effectively kill tumor cells and reduce collateral damages to healthy cells.
 
Another property that makes this delivery system quite unique is its reversibility. Because the extension and retraction actions are purely mechanical, they can be controlled with great precision and can be re-used over and over again. This is highly beneficial considering the many compartments that are contained in eukaryotic cells.
 
The sky seems to be the limit for these new biological actuators. “By decorating these polymers with different kinds of metals or other materials with properties of interest, we could potentially develop a range of actuator-like, nanoscale structures," said Silver.
 
"There are so many amazing mechanisms engineered by Nature, and this is a great example of how we can mine living systems for unique biological elements and adapt them to develop programmable technologies for high value applications using synthetic biology," said Donald Ingber, Wyss Institute Founding Director.
 

Additional source: Wyss Institute
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 06, 2018
Clinical & Molecular DX
MAR 06, 2018
Diagnosing and Treating An Extremely Rare Genetic Disease: Progeria
An extremely rare genetic disease that causes accelerated aging and heart disease has been little studied, largely due to a lack of relevant animal models.
MAR 14, 2018
Neuroscience
MAR 14, 2018
A Surprising Finding in Multiple Sclerosis Research
Multiple sclerosis (MS) is a devastating neurological disorder that is thought to be caused by a problem with the immune system. MS causes the body to atta
MAR 19, 2018
Clinical & Molecular DX
MAR 19, 2018
Streamlining Diagnostic Tests for Designer Drugs
Current tests for new “designer drugs” like fentanyl and synthetic cannabinoids are incompatible with emergency medical situations. Detection r
APR 24, 2018
Cancer
APR 24, 2018
CAR-T Cell Therapy 101
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a useful tool for cancer treatments in a small number of cancers thus far. This area of treatment research is expanding rapidl
MAY 26, 2018
Clinical & Molecular DX
MAY 26, 2018
Testing for Liver Disease, Before Symptoms Appear
A diagnostic test for liver damage has been developed, one that can be used before symptoms even begin to appear.
JUN 12, 2018
Cell & Molecular Biology
JUN 12, 2018
Loss of Brain Lesions may Indicate Worsening MS
New research could help doctors determine how severe a case of multiple sclerosis will become.
Loading Comments...